Seller record · Telehealth service

QuickMD

Fails 4 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The weight loss page and the terms say prescriptions go to the pharmacy of the patient's choice or an eligible delivery service. 3 more criteria also fail; see the table below.

At a glance

QuickMDTelehealth service

4/8criteria passed
Price
Not printed before a consultation or sign-up
Sells
Ozempic, Wegovy, Mounjaro, and 4 more
FDA letters
None on file
Visit QuickMDSee all eight dispositions

Telehealth service. Passes 4 of 8 criteria. Recorded against Standard v1.1.

A national pay-per-visit telemedicine company offering online addiction treatment, mental health, hormone and urgent care, whose weight loss consultations prescribe brand-name GLP-1s such as Ozempic, Wegovy, Mounjaro and Zepbound to the patient's own pharmacy. Its compounded GLP-1 pages say those drugs are no longer offered.

Operating entity QuickMD, LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSQuickMD's weight loss page; QuickMD's pricing page
S2Prescription gatingPASSQuickMD's get in touch page; QuickMD's pricing page
S3Pharmacy identificationFAILQuickMD's weight loss page; QuickMD's terms of service page
S4Compounding disclosurePASSQuickMD's get a compounded semaglutide prescription page; QuickMD's weight loss page
S5Analytical documentationFAILQuickMD's weight loss page; QuickMD's FAQ; QuickMD's terms of service page
S6Business addressFAILQuickMD's terms of service page
S7Price disclosureFAILQuickMD's pricing page; QuickMD's weight loss page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed clinician reviews each patient's health history, current medications and goals in a virtual weight loss visit and prescribes a GLP-1 only if appropriate.Source: QuickMD's weight loss page; QuickMD's pricing page.
S2PASSA prescription follows only a visit with a licensed doctor, and the $99 weight loss consultation pays for that visit. The answers say payment details confirm the booking and the intake form is completed before the appointment.Source: QuickMD's get in touch page; QuickMD's pricing page.
S3FAILNo filling pharmacy is named. The weight loss page and the terms say prescriptions go to the pharmacy of the patient's choice or an eligible delivery service.Source: QuickMD's weight loss page; QuickMD's terms of service page.
S4PASSThe GLP-1s prescribed are brand drugs, and the compounded semaglutide and tirzepatide pages say the compounded versions are no longer available. The answers distinguish FDA-approved brand-name GLP-1s from compounded medications.Source: QuickMD's get a compounded semaglutide prescription page; QuickMD's weight loss page.
S5FAILNo certificate of analysis or lot document is published on the weight loss pages, the answers or the terms.Source: QuickMD's weight loss page; QuickMD's FAQ; QuickMD's terms of service page.
S6FAILThe seller prints two different addresses. The terms give QuickMD, LLC at 3415 S Sepulveda Blvd, Fl 10, Los Angeles, CA 90034 for legal notices, while their contact block gives QuickMD, Inc. at 3865 Holcomb Bridge Rd, Peachtree Corners, GA 30092.Source: QuickMD's terms of service page.
S7FAILNo medication price is printed. The weight loss consultation costs $99, and the pages say medication costs vary with the drug prescribed and the pharmacy chosen.Source: QuickMD's pricing page; QuickMD's weight loss page.
S8PASSNo FDA warning letter names QuickMD or QuickMD, LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, liraglutide, menopause hormone therapy.

Visit QuickMD

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.